Iron supplementation in patients with anemia

Not Applicable

Completed

• Conditions: Moderate and severe anemia; Haematological Disorders

• Registration Number: ISRCTN96148278
• Lead Sponsor: Padjadjaran University

Brief Summary

2023 Results article in https://dx.doi.org/10.15296/ijwhr.2023.02 (added 20/04/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-11-29
• Study Start: 2022-10-25
• Last Update Posted: 1 May 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 110

Inclusion Criteria

1. Moderate and severe anemia
2. Aged between 15–49 years
3. Consented to take part in the study

Exclusion Criteria

1. Did not complete the informed consent
2. Incomplete data collected pre and post session
3. Unable to communicate

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin level measured using the portable analyzer HemoCue 201 at baseline and 30 days

Secondary Outcome Measures

Name	Time	Method
Correlation factors to the success of anemia therapy such as ethnicity, adherence to MARS and pill counting methods, and the type of supplementation, measured at baseline and 30 days